Vistagen Therapeutics (VTGN) EBIT Margin (2011 - 2026)
Vistagen Therapeutics' EBIT Margin was -904.34% in fiscal Q1 2027 (quarter ended Jun 30, 2026), up 5572.71 percentage points from -6477.05% a year earlier and up 2690.72 percentage points from the prior quarter.
Vistagen Therapeutics (VTGN) EBIT Margin (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Vistagen Therapeutics' EBIT Margin was -2784.33% through Jun 30, 2026, up 6448.79 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -5683.69%, up 5833.39 percentage points from FY2025.
- EBIT Margin shows a five-year change of -4037.63 percentage points (FY2021 to FY2026).
- In earlier fiscal years, EBIT Margin was -11517.08% in FY2025 (-8413.60 pp), -3103.48% in FY2024 (+23005.77 pp), -26109.25% in FY2023 (-21800.96 pp) and -4308.30% in FY2022 (-2662.24 pp).
- The fiscal Q1 2027 figure marks the highest quarterly EBIT Margin since fiscal Q3 2017.
- Compared with a year earlier, EBIT Margin was higher in four of the last six quarters, with an average year-over-year change of +582.05 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was fiscal Q4 2023 (a gain of 35848.59 percentage points); the worst was fiscal Q4 2022 (a drop of 41395.55 percentage points).
- Per Business Quant data, VTGN's EBIT Margin in the three fiscal quarters before Q1 2027 was -3595.05% (Q4 2026), -6450.83% (Q3 2026) and -7772.48% (Q2 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn | 28.37% |
| 10 | Vistagen Therapeutics | 8.65 Mn | -207.43 Mn | - | -904.34% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -904.34% |
| Mar 31, 2026 | -3,595.05% |
| Dec 31, 2025 | -6,450.83% |
| Sep 30, 2025 | -7,772.48% |
| Jun 30, 2025 | -6,477.05% |
| Dec 31, 2024 | -6,461.54% |
| Sep 30, 2024 | -7,774.32% |
| Jun 30, 2024 | -14,441.67% |
| Mar 31, 2024 | -6,926.22% |
| Dec 31, 2023 | -1,918.25% |
| Sep 30, 2023 | -2,260.00% |
| Jun 30, 2023 | -3,499.00% |
| Mar 31, 2023 | -6,953.98% |
| Dec 31, 2022 | -5,425.83% |
| Sep 30, 2022 | -1,958.49% |
| Jun 30, 2022 | -6,376.36% |
| Mar 31, 2022 | -42,802.56% |
| Dec 31, 2021 | -2,943.85% |
| Sep 30, 2021 | -3,575.42% |
| Jun 30, 2021 | -2,188.42% |
Vistagen Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();